East Shines Over West? US Rejection Puts Roxadustat's China Approval In New Spotlight

Japan, EU Offer Other Growth Alternatives?

Blood cells
FIBROGEN'S ROXADUSTAT REJECTED IN US BUT CHINA, JAPAN, EU PRESENT OTHER OPPORTUNITIES • Source: Alamy

More from China

More from Focus On Asia